H
HY-Lok Corp
KOSDAQ:013030
HY-Lok Corp
KOSDAQ:013030
Price:
26 550
KRW
3.11%
Market Closed
Market Cap:
306.4B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
HY-Lok Corp
26550
+800 (+3.11%)
| 52 Week Range |
22 450
29 450
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
HY-Lok Corp
Balance Sheet
Balance Sheet Decomposition
HY-Lok Corp
HY-Lok Corp
| Current Assets | 334.8B |
| Cash & Short-Term Investments | 182.7B |
| Receivables | 45.1B |
| Other Current Assets | 106.9B |
| Non-Current Assets | 108.4B |
| Long-Term Investments | 19.2B |
| PP&E | 72.7B |
| Intangibles | 7.8B |
| Other Non-Current Assets | 8.6B |
| Current Liabilities | 25.8B |
| Accounts Payable | 4.8B |
| Accrued Liabilities | 2.5B |
| Other Current Liabilities | 18.5B |
| Non-Current Liabilities | 13.9B |
| Other Non-Current Liabilities | 13.9B |
Balance Sheet
HY-Lok Corp
HY-Lok Corp
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
92 245
|
113 889
|
122 399
|
129 279
|
31 208
|
24 567
|
38 295
|
66 057
|
55 323
|
170 179
|
|
| Cash |
17 073
|
20 212
|
9 714
|
38 499
|
17 521
|
8 719
|
9 113
|
9 527
|
10 445
|
14 978
|
|
| Cash Equivalents |
75 172
|
93 677
|
112 685
|
90 780
|
13 687
|
15 848
|
29 182
|
56 530
|
44 878
|
155 201
|
|
| Short-Term Investments |
3 044
|
2 132
|
1 513
|
24 232
|
106 660
|
129 243
|
116 061
|
110 029
|
128 634
|
12 558
|
|
| Total Receivables |
57 653
|
53 182
|
55 247
|
54 646
|
47 713
|
45 588
|
37 798
|
36 780
|
44 787
|
45 108
|
|
| Accounts Receivables |
55 029
|
51 912
|
54 666
|
53 695
|
47 526
|
44 280
|
36 920
|
35 841
|
43 535
|
44 293
|
|
| Other Receivables |
2 624
|
1 270
|
581
|
951
|
187
|
1 308
|
878
|
939
|
1 252
|
816
|
|
| Inventory |
62 941
|
65 971
|
67 188
|
51 000
|
65 096
|
68 719
|
72 862
|
68 130
|
84 950
|
106 226
|
|
| Other Current Assets |
2 228
|
2 450
|
2 186
|
2 374
|
1 647
|
1 110
|
838
|
623
|
1 039
|
687
|
|
| Total Current Assets |
218 110
|
237 624
|
248 534
|
261 530
|
252 324
|
269 227
|
265 854
|
281 619
|
314 734
|
334 759
|
|
| PP&E Net |
69 574
|
78 858
|
78 001
|
84 552
|
85 109
|
82 044
|
72 235
|
70 810
|
70 698
|
72 739
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
82 044
|
72 235
|
70 810
|
70 698
|
72 739
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
50 979
|
48 626
|
52 157
|
55 181
|
57 931
|
|
| Intangible Assets |
6 716
|
6 441
|
5 542
|
5 572
|
5 710
|
5 756
|
6 069
|
6 429
|
6 370
|
6 380
|
|
| Goodwill |
1 685
|
1 685
|
1 685
|
6 963
|
6 963
|
6 963
|
1 685
|
1 685
|
1 407
|
1 407
|
|
| Note Receivable |
4 769
|
6 472
|
6 920
|
1 452
|
1 647
|
1 438
|
2 390
|
2 292
|
2 449
|
1 952
|
|
| Long-Term Investments |
4 348
|
3 650
|
10 463
|
15 964
|
15 381
|
12 215
|
12 076
|
11 937
|
11 798
|
19 225
|
|
| Other Long-Term Assets |
337
|
491
|
2 180
|
3 404
|
4 188
|
3 663
|
4 741
|
5 023
|
4 466
|
6 693
|
|
| Other Assets |
1 685
|
1 685
|
1 685
|
6 963
|
6 963
|
6 963
|
1 685
|
1 685
|
1 407
|
1 407
|
|
| Total Assets |
305 540
N/A
|
335 220
+10%
|
353 324
+5%
|
379 437
+7%
|
371 321
-2%
|
381 305
+3%
|
365 051
-4%
|
379 796
+4%
|
411 922
+8%
|
443 155
+8%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
12 511
|
9 325
|
7 207
|
5 690
|
5 812
|
6 242
|
6 199
|
4 979
|
7 133
|
4 808
|
|
| Accrued Liabilities |
3 020
|
1 529
|
1 504
|
1 415
|
2 121
|
2 086
|
2 149
|
2 204
|
2 253
|
2 497
|
|
| Short-Term Debt |
20 000
|
15 000
|
15 000
|
15 000
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
2 000
|
2 000
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
15 257
|
18 705
|
12 542
|
10 174
|
8 690
|
10 443
|
12 041
|
14 144
|
18 611
|
18 489
|
|
| Total Current Liabilities |
50 788
|
44 559
|
36 253
|
34 279
|
18 623
|
18 771
|
20 389
|
21 327
|
27 997
|
25 794
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
2 000
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
1 036
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
3 372
|
3 560
|
3 330
|
7 004
|
7 261
|
7 525
|
3 309
|
3 440
|
2 969
|
3 350
|
|
| Other Liabilities |
4 840
|
5 277
|
8 219
|
10 180
|
10 053
|
11 489
|
11 587
|
10 371
|
3 799
|
10 502
|
|
| Total Liabilities |
60 036
N/A
|
53 396
-11%
|
47 802
-10%
|
51 462
+8%
|
35 937
-30%
|
39 785
+11%
|
35 286
-11%
|
35 138
0%
|
34 765
-1%
|
39 646
+14%
|
|
| Equity | |||||||||||
| Common Stock |
6 807
|
6 807
|
6 807
|
6 807
|
6 807
|
6 807
|
6 807
|
6 807
|
6 807
|
6 807
|
|
| Retained Earnings |
214 846
|
251 199
|
275 190
|
297 863
|
305 172
|
311 116
|
309 367
|
323 416
|
355 842
|
379 921
|
|
| Additional Paid In Capital |
23 844
|
23 959
|
23 959
|
23 844
|
23 844
|
23 844
|
23 844
|
23 844
|
23 844
|
23 844
|
|
| Unrealized Security Profit/Loss |
0
|
358
|
579
|
193
|
193
|
193
|
193
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
9 933
|
9 933
|
9 933
|
7 928
|
|
| Other Equity |
8
|
217
|
146
|
345
|
245
|
52
|
127
|
525
|
598
|
866
|
|
| Total Equity |
245 505
N/A
|
281 824
+15%
|
305 522
+8%
|
327 975
+7%
|
335 384
+2%
|
341 521
+2%
|
329 765
-3%
|
344 658
+5%
|
377 157
+9%
|
403 509
+7%
|
|
| Total Liabilities & Equity |
305 540
N/A
|
335 220
+10%
|
353 324
+5%
|
379 437
+7%
|
371 321
-2%
|
381 305
+3%
|
365 051
-4%
|
379 796
+4%
|
411 922
+8%
|
443 155
+8%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
14
|
14
|
14
|
14
|
14
|
14
|
13
|
13
|
13
|
13
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
